Cystadenocarcinoma

Cystadenocarcinoma is a type of cancer that starts in the glands that make up your body's tissues. It often forms cysts, which are fluid-filled sacs. This cancer can occur in various parts of the body, including the ovaries. It's a serious condition that needs medical treatment.

Condition

What people with Cystadenocarcinoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Carboplatin for Cystadenocarcinoma?

NameHow it went

About Cystadenocarcinoma

What It Is

Cystadenocarcinoma is a cancer that starts in glandular tissue, the cells that line an organ and make fluid or mucus. As the tumor grows, that fluid collects inside it and forms cysts, which is where the name comes from. Unlike a simple cyst, a cystadenocarcinoma can grow into nearby tissue and spread to other parts of the body. Most cystadenocarcinomas start in the ovary. The two main types are serous, which makes thin, watery fluid, and mucinous, which makes thick mucus. Pathology reports may use more specific names for the same tumors, such as high-grade serous carcinoma, the most common type of ovarian cancer, or low-grade serous carcinoma, a less common type that tends to affect younger women and grow more slowly. Doctors group ovarian cystadenocarcinoma with fallopian tube and primary peritoneal cancer (cancer of the lining of the abdomen) because they come from the same kind of tissue and are treated the same way. Less often, a cystadenocarcinoma develops in the pancreas. It is important to tell this cancer apart from its benign relative, the cystadenoma, and from borderline tumors, which have some abnormal cells but do not invade surrounding tissue. Ovarian cystadenocarcinoma matters because it often causes few symptoms until it has already spread within the abdomen.

Causes & Risk Factors

Ovarian cystadenocarcinoma develops when cells build up changes in their DNA, and the reason those changes happen is usually unknown. Age is the main risk factor, and risk is highest after menopause. About 1 in 5 ovarian cancers is linked to an inherited gene change. The best known are changes in the BRCA1 and BRCA2 genes, which also raise the risk of breast cancer, and Lynch syndrome, which also raises the risk of colon and uterine cancer. A mother, sister or daughter with ovarian cancer increases risk. Other factors linked to higher risk include endometriosis, hormone therapy after menopause, obesity, being tall and never having been pregnant. These are associations, not causes, and most people with a risk factor never develop this cancer. For people with a strong inherited risk, surgery to remove the ovaries and fallopian tubes before cancer develops greatly lowers the chance of ovarian cancer.

How It's Diagnosed

Evaluation usually starts with symptoms such as belly swelling or pelvic pain, followed by a pelvic exam and imaging. A transvaginal ultrasound, in which a small probe placed in the vagina uses sound waves to picture the ovaries, can show whether a mass is a simple fluid-filled cyst or has solid areas and thick walls that raise concern. CT, MRI or PET scans show whether anything has spread within the abdomen or beyond. A blood test for CA-125, a protein many ovarian cancers release, is often ordered. A high level supports the suspicion of cancer but does not prove it, because endometriosis and other noncancerous conditions can also raise it, and some cancers do not raise it at all. A normal result does not rule cancer out. The diagnosis is confirmed only when a pathologist examines tissue under a microscope, and that tissue is usually removed during surgery. The same operation helps determine the stage, from stage I (cancer limited to one or both ovaries or fallopian tubes) through stage IV (spread beyond the abdomen, such as fluid around the lungs or the liver). Everyone diagnosed with this type of ovarian cancer should be offered genetic testing for BRCA1, BRCA2 and related genes, and the tumor itself can also be tested. The results help decide which treatments are likely to work, and an inherited gene change can matter for relatives as well.

Treatment Options

Treatment depends on where the cancer started, its type and its stage, and is best planned by a gynecologic oncologist, a surgeon who specializes in cancers of the female reproductive organs. For ovarian cystadenocarcinoma, surgery is the foundation. The surgeon usually removes the uterus, both ovaries and fallopian tubes, and the omentum (a fatty apron of tissue in the abdomen that cancer often reaches), and samples lymph nodes. In advanced disease the goal is to remove all visible cancer, because how much remains after surgery strongly affects the outlook. For some early cancers in people who want to have children, removing only the affected ovary and tube may be possible. Most people also receive chemotherapy that includes a platinum drug, usually carboplatin, often given with paclitaxel. It is typically given after surgery, but when the cancer is widespread it may be given first to shrink it and make surgery more effective. Some people receive part of their chemotherapy directly into the abdomen through a thin tube. Even in early-stage cancer, chemotherapy after surgery has been shown to improve survival for many patients. After chemotherapy works, maintenance treatment can help keep the cancer from returning for longer. PARP inhibitors, such as olaparib (Lynparza) and niraparib (Zejula), are daily pills that block a DNA repair system cancer cells rely on. They work best in cancers with a BRCA change or a related repair defect, which is one reason genetic and tumor testing matter. Bevacizumab (Avastin) is an intravenous drug that blocks a signal tumors use to grow new blood vessels, and it can be added to chemotherapy or maintenance. These drugs bring their own side effects, such as fatigue, nausea and low blood counts, that need regular monitoring. Cancer that comes back is usually treated again with chemotherapy, targeted drugs or sometimes more surgery, and clinical trials are an option at any stage. Pancreatic cystadenocarcinoma usually arises from a mucinous cystic tumor of the pancreas. Surgery to remove the affected part of the pancreas is the main treatment, and chemotherapy afterward follows the approach used for more common pancreatic cancer, although evidence specific to this rare tumor is limited.

What to Expect

The outlook varies widely. It depends on the type of tumor, the stage at diagnosis, whether all visible cancer could be removed, whether the cancer carries a BRCA change, and a person's age and overall health. Cancer found while still confined to the ovary has a much better outlook than cancer that has spread, but most ovarian cystadenocarcinomas, especially high-grade serous ones, are found after they have spread within the abdomen. Initial treatment usually takes several months: recovery from major abdominal surgery, followed by chemotherapy given every few weeks. Fatigue, hair loss, nausea, numbness or tingling in the hands and feet, and a higher risk of infection are common during this time. Removing both ovaries ends fertility and stops the ovaries' hormone production, which brings on menopause for people who had not yet reached it. These effects are worth discussing before surgery. Ovarian cancer often returns after a good first response, sometimes after months or years without signs of disease. Many people live with it as a long-term condition, moving through periods of treatment and periods of monitoring. Follow-up visits typically include exams, symptom review and, when needed, CA-125 tests or scans. Support from palliative care teams, which focus on symptoms and quality of life at any stage, counselors and others who have been through treatment can help with the physical and emotional load.

When to Seek Help

See a doctor if you have belly or pelvic pain, swelling, pressure, bloating, feeling full quickly or a frequent urge to urinate that is new and does not go away over a few weeks. These symptoms usually have other causes, but persistent ones deserve evaluation, especially with a family history of ovarian or breast cancer. During chemotherapy, call your care team right away for a fever of 100.5°F (38°C) or higher, shaking chills or other signs of infection, because treatment can lower the white blood cells that fight infection. Get emergency care for repeated vomiting, a hard and swollen belly with intense pain, or being unable to pass gas or stool. These can be signs of a blocked bowel, a serious complication of cancers in the abdomen that needs immediate treatment.

Questions to Ask Your Doctor

  1. 1.What type and stage is my cancer, and what does that mean for my treatment goals?
  2. 2.Will my surgery be done by a gynecologic oncologist, and do you expect to remove all visible cancer?
  3. 3.What did my genetic and tumor testing show, and does it make me a candidate for maintenance treatment such as a PARP inhibitor?
  4. 4.Will treatment affect my fertility or bring on menopause, and what are my options before surgery?
  5. 5.How will we watch for the cancer coming back, and what symptoms should prompt me to call between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.